1![Microsoft Word - About Ferring - fact sheet_31Mar15.doc Microsoft Word - About Ferring - fact sheet_31Mar15.doc](https://www.pdfsearch.io/img/46c05fe2758d0e3240318e03b12271dc.jpg) | Add to Reading ListSource URL: www.ferring.comLanguage: English - Date: 2015-03-31 03:39:33
|
---|
2![PATEY
2
Thursday
8th
January
2015,
14.15
-‐
15.25
7
papers
(7
min
+
3
min)
O8 THE EFFECTS OF TERLIPRESSIN AND DIRECT PORTOCAVAL SHUNTING ON LIVER PATEY
2
Thursday
8th
January
2015,
14.15
-‐
15.25
7
papers
(7
min
+
3
min)
O8 THE EFFECTS OF TERLIPRESSIN AND DIRECT PORTOCAVAL SHUNTING ON LIVER](https://www.pdfsearch.io/img/fcc0ed74490e1fa647595628b388c6c7.jpg) | Add to Reading ListSource URL: www.surgicalresearch.org.ukLanguage: English - Date: 2014-12-14 10:17:07
|
---|
3![Brochure More information from http://www.researchandmarkets.com/reports[removed]Hepatorenal Syndrome - Pipeline Review, H2 2012 Description: Brochure More information from http://www.researchandmarkets.com/reports[removed]Hepatorenal Syndrome - Pipeline Review, H2 2012 Description:](https://www.pdfsearch.io/img/bc862ed4eb39f990bca14bb11ab07b5f.jpg) | Add to Reading ListSource URL: www.researchandmarkets.comLanguage: English |
---|
4![FOR IMMEDIATE RELEASE FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN® -- Priority Review Granted -Lebanon, NJ, and Clinton, NJ, June 12, 2009 – Orphan Therapeutics, LLC and Ikaria Holdings, Inc. announced today FOR IMMEDIATE RELEASE FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN® -- Priority Review Granted -Lebanon, NJ, and Clinton, NJ, June 12, 2009 – Orphan Therapeutics, LLC and Ikaria Holdings, Inc. announced today](https://www.pdfsearch.io/img/337e632d02618d7963c327a3f16f1038.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:52:57
|
---|
5![IKARIA® BEGINS ENROLLMENT OF PIVOTAL TRIAL FOR LUCASSIN® Clinton, NJ, November 30, 2010 – Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). T IKARIA® BEGINS ENROLLMENT OF PIVOTAL TRIAL FOR LUCASSIN® Clinton, NJ, November 30, 2010 – Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). T](https://www.pdfsearch.io/img/c97c3c57c1a50be7538d990324ce34ae.jpg) | Add to Reading ListSource URL: www.ikaria.comLanguage: English - Date: 2011-06-28 11:53:05
|
---|
6![Microsoft Word - About Ferring - fact sheet_SNY_25Mar14 Microsoft Word - About Ferring - fact sheet_SNY_25Mar14](https://www.pdfsearch.io/img/cb55108c1e3e8f690f6c2f2740d58b8a.jpg) | Add to Reading ListSource URL: www.ferring.comLanguage: English - Date: 2014-03-25 09:41:49
|
---|